Advertisement

Medical Devices

FDA user-fee extension breezes through Senate committee

FDA user-fee extension breezes through Senate committee

The act, which calls for more than $400 million in additional user fees to be collected from the makers of prescription brand drugs, medical devices, generic drugs and biosimilars, looks to expedite new drug approvals. The committee added amendments aimed at increasing competition.

Imaging use plunges as coding, reimbursement tightens up

Medical imaging use in the U.S. has dropped significantly after years of widespread growth, leading to curtailed hiring, equipment purchases and reduced access to the technology thanks to cuts in federal reimbursement and new coding arrangements, according to a new study.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print